진단용 심전계(ECG) 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품 유형별, 채널별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Diagnostic Electrocardiograph Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Channel, By End Use, By Region and Competition, 2020-2030F
상품코드:1667919
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
진단용 심전계 세계 시장 규모는 2024년 84억 7,000만 달러로 평가되었고, 예측 기간 동안 7.12%의 연평균 복합 성장률(CAGR)로 2030년에는 128억 3,000만 달러에 달할 것으로 예상됩니다.
세계 진단용 심전계 시장은 전 세계 심혈관 질환(CVD) 유병률 증가, 고령화 인구 증가, 심전도 기술의 발전 등에 힘입어 성장하고 있습니다. 생활습관의 변화, 비만, 앉아있는 습관 등으로 인해 심장질환이 보편화됨에 따라 정확하고 사용하기 쉬운 진단 도구에 대한 수요가 증가하고 있습니다. 휴대용 심전도 기기, 무선 기술, 인공지능의 통합과 같은 기술 혁신도 진단 과정을 보다 효율적이고 쉽게 이용할 수 있게 함으로써 시장 확대에 기여하고 있습니다. 또한, 의료 투자 증가, 의료 인프라 개선, 예방 의료에 대한 관심 증가가 시장 성장을 뒷받침하고 있습니다. 규제 당국의 승인과 인식 제고 캠페인은 선진국과 신흥국 시장 모두에서 ECG 기기 채택을 더욱 촉진하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
84억 7,000만 달러
시장 규모 : 2030년
128억 3,000만 달러
CAGR(2025-2030년)
7.12%
급성장 부문
안정시 심전도 장치
최대 시장
북미
시장 성장 촉진요인
심혈관 질환(CVD) 유병률 증가
주요 시장 과제
고급 ECG 장비의 높은 비용
주요 시장 동향
재택의료 솔루션 도입 확대
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 진단용 심전계(ECG) 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
제품 유형별(안정시 심전도 장비, 스트레스 심전도 장비, 홀터 심전도 모니터, 기타)
채널별(12채널, 6채널, 5채널, 3채널, 싱글 채널)
용도별(병원 클리닉, 외래수술센터(ASC), 심장 케어 센터, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 진단용 심전계(ECG) 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
캐나다
멕시코
제7장 유럽의 진단용 심전계(ECG) 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 진단용 심전계(ECG) 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
인도
일본
한국
호주
제9장 남미의 진단용 심전계(ECG) 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 진단용 심전계(ECG) 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(M&A)(해당하는 경우)
제품 발매(해당하는 경우)
제13장 Porter의 Five Forces 분석
산업내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
General Electric Company
Koninklijke Philips N.V.
Nihon Kohden Corporation
Ambu A/S
Spacelabs Healthcare, Inc.
AliveCor, Inc.
Mindray Medical India Pvt. Ltd.
Hill-Rom Holdings, Inc.
Bpl Medical Technologies Pvt. Ltd.
Bardy Diagnostics, Inc.
제15장 전략적 제안
제16장 리서치사에 대해 & 면책사항
LSH
영문 목차
영문목차
Global Diagnostic Electrocardiograph Market was valued at USD 8.47 Billion in 2024 and is expected to reach USD 12.83 Billion by 2030 with a CAGR of 7.12% during the forecast period. The global diagnostic Electrocardiograph Market is being driven by the increasing prevalence of cardiovascular diseases (CVDs) worldwide, a rising aging population, and advancements in ECG technology. As heart conditions become more common due to lifestyle changes, obesity, and sedentary habits, the demand for accurate and accessible diagnostic tools has grown. Innovations such as portable ECG devices, wireless technology, and artificial intelligence integration are also contributing to market expansion by making diagnostic processes more efficient and accessible. Additionally, increasing healthcare investments, improving healthcare infrastructure, and a growing emphasis on preventive care are supporting market growth. Regulatory approvals and awareness campaigns further promote the adoption of ECG devices in both developed and emerging markets.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 8.47 Billion
Market Size 2030
USD 12.83 Billion
CAGR 2025-2030
7.12%
Fastest Growing Segment
Resting ECG Devices
Largest Market
North America
Key Market Drivers
Increasing Prevalence of Cardiovascular Diseases (CVDs)
The increasing prevalence of cardiovascular diseases (CVDs) is a key driver of the diagnostic Electrocardiograph Market. CVDs, which include heart attacks, coronary artery disease, strokes, arrhythmias, and heart failure, are responsible for a significant percentage of global morbidity and mortality. According to the World Health Organization (WHO), CVDs account for approximately 31% of all global deaths, making them the leading cause of death worldwide. The rise in CVDs can be attributed to several factors, including poor lifestyle choices such as unhealthy diets, lack of physical activity, smoking, high alcohol consumption, and stress. According to Centers for Disease Control and Prevention, Heart disease is the leading cause of death for both men and women, as well as for individuals across most racial and ethnic groups. Every 33 seconds, someone dies from cardiovascular disease. In 2022 alone, heart disease was responsible for 702,880 deaths, accounting for roughly one in every five deaths.
Additionally, the aging population contributes to the rising incidence of heart conditions, as older adults are more likely to develop cardiovascular problems. As the global population continues to grow and age, the demand for diagnostic ECG tools is increasing to help identify heart diseases at an early stage. ECGs are essential for detecting irregular heart rhythms (arrhythmias), heart attacks, and other cardiovascular abnormalities, often before symptoms become severe. Early diagnosis and intervention significantly improve patient outcomes by reducing complications and even preventing premature death. Consequently, the global burden of CVDs is creating a sustained demand for ECG devices, with a focus on both preventive screenings and ongoing patient monitoring.
Key Market Challenges
High Cost of Advanced ECG Devices
Despite significant technological advancements, the cost of high-quality ECG devices, especially advanced models with features such as wireless connectivity, AI integration, and portable designs, remains a barrier for widespread adoption, particularly in low- and middle-income countries. These devices often require significant capital investment, both for healthcare providers and patients. High-end ECG machines, used in hospitals and clinics, can be expensive, and the associated maintenance and training costs further add to the financial burden. While the use of more affordable, portable ECG devices is on the rise, the price remains a challenge for many healthcare institutions, especially in rural areas with limited budgets. As such, the high cost of these devices limits their accessibility, especially in resource-constrained environments, slowing down their adoption in global markets.
Key Market Trends
Growing Adoption of Home Healthcare Solutions
Home healthcare is a rapidly growing sector, driven by the increasing preference for receiving care in a more comfortable and familiar setting. Patients and healthcare providers alike are realizing the benefits of home-based care, such as convenience, affordability, and the ability to monitor health continuously. This trend is particularly evident among individuals with chronic health conditions, such as heart disease, who require regular monitoring. In July 2024, Project SPANDAN is a transformative initiative focused on improving the management of hypertension and diabetes in primary healthcare facilities across Madhya Pradesh, India. In collaboration with Resolve to Save Lives and JHPIEGO, the project aims to enhance comprehensive primary healthcare systems to better cardiovascular health. It will provide crucial state-level support and district-level assistance in selected intervention areas to strengthen local healthcare capabilities.
Key Market Players
General Electric Company
Koninklijke Philips N.V.
Nihon Kohden Corporation
Ambu A/S
Spacelabs Healthcare, Inc.
AliveCor, Inc.
Mindray Medical India Pvt. Ltd.
Hill-Rom Holdings, Inc.
Bpl Medical Technologies Pvt. Ltd.
Bardy Diagnostics, Inc.
Report Scope:
In this report, the Global Diagnostic Electrocardiograph Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Diagnostic Electrocardiograph Market, By Product Type:
Resting ECG Devices
Stress ECG Devices
Holter Monitors
Others
Diagnostic Electrocardiograph Market, By Channel:
12-channel
6-channel
5- channel
3- channel
Single- channel
Diagnostic Electrocardiograph Market, By End Use:
Hospitals & Clinics
Ambulatory Surgical Centers
Cardiac Care Centers
Others
Diagnostic Electrocardiograph Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Electrocardiograph Market.
Available Customizations:
Global Diagnostic Electrocardiograph market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Diagnostic Electrocardiograph Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Others)
